SARISSA BIOMEDICAL LIMITED
SARISSA BIOMEDICAL LIMITED is a private limited company registered in the United Kingdom, under 04581254, incorporated on 4 November 2002. The company is currently suspended. Operates in the manufacture of basic pharmaceutical products sector (SIC 21100). Registered office address: SO15 2NP Southampton, the United Kingdom. Directors include NICHOLAS EGERTON DALE, DR JOHN MICHAEL CLARKSON, and MERCIA FUND MANAGEMENT (NOMINEES) LIMITED, and 2 others. Sole shareholder is MERCIA FUND MANAGEMENT LIMITED. Associated with 20 related entities, including SC278124, 6 BIT EDUCATION LTD, and 11181780. The overall risk score is 0/100 (negligible). Accounts next due 2021-09-30, overdue as of 2026-03-02. Confirmation statement next due 2021-11-18, overdue as of 2026-03-02. Data sourced from UK Companies House.
Official Identifiers
Registered Address
C/O JAMES COWPER KRESTON THE WHITE BUILDING
1-4 CUMBERLAND PLACE
SO15 2NP SOUTHAMPTON
the United Kingdom
Entity Risk Evaluation
Signal Intelligence (2)
| Type | Severity | Description | Detected |
|---|---|---|---|
| confirmation statement overdue | MEDIUM | Confirmation statement next due 2021-11-18, overdue as of 2026-03-02 | — |
| accounts overdue | MEDIUM | Accounts next due 2021-09-30, overdue as of 2026-03-02 | — |
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 04581254 | 2026-04-30 | open_in_new |